serw-MX  [xml]  
 


    
 DeCS Categories

A11 Cells .
A11.148 Bone Marrow Cells .
A11.148.378 Hematopoietic Stem Cells .
A11.148.378.590 Myeloid Progenitor Cells .
A11.148.378.590.675 Granulocyte-Macrophage Progenitor Cells .
A11.148.378.590.675.750 Monocyte-Macrophage Precursor Cells .
A11.148.580 Monocytes .
A11.148.580.500 Monocyte-Macrophage Precursor Cells .
A11.627 Myeloid Cells .
A11.627.482 Macrophages .
A11.627.482.665 Monocyte-Macrophage Precursor Cells .
A11.627.624 Monocytes .
A11.627.624.249 Monocyte-Macrophage Precursor Cells .
A11.627.635 Myeloid Progenitor Cells .
A11.627.635.675 Granulocyte-Macrophage Progenitor Cells .
A11.627.635.675.750 Monocyte-Macrophage Precursor Cells .
A11.872 Stem Cells .
A11.872.378 Hematopoietic Stem Cells .
A11.872.378.590 Myeloid Progenitor Cells .
A11.872.378.590.635 Granulocyte-Macrophage Progenitor Cells .
A11.872.378.590.635.875 Monocyte-Macrophage Precursor Cells .
A15 Hemic and Immune Systems .
A15.378 Hematopoietic System .
A15.378.316 Bone Marrow Cells .
A15.378.316.378 Hematopoietic Stem Cells .
A15.378.316.378.590 Myeloid Progenitor Cells .
A15.378.316.378.590.675 Granulocyte-Macrophage Progenitor Cells .
A15.378.316.378.590.675.750 Monocyte-Macrophage Precursor Cells .
B01 Eukaryota .
B01.050 Animals .
B01.050.150 Chordata .
B01.050.150.900 Vertebrates .
B01.050.150.900.649 Mammals .
B01.050.150.900.649.313 Eutheria .
B01.050.150.900.649.313.750 Carnivora .
B01.050.150.900.649.313.750.600 Caniformia .
B01.050.150.900.649.313.750.600.623 Procyonidae .
B01.050.150.900.649.313.750.600.623.700 Raccoons .
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.465 Neoplasms, Germ Cell and Embryonal .
C04.557.465.625 Neuroectodermal Tumors .
C04.557.465.625.600 Neoplasms, Neuroepithelial .
C04.557.465.625.600.380 Glioma .
C04.557.465.625.600.380.080 Astrocytoma .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.670 Neoplasms, Neuroepithelial .
C04.557.470.670.380 Glioma .
C04.557.470.670.380.080 Astrocytoma .
C04.557.580 Neoplasms, Nerve Tissue .
C04.557.580.625 Neuroectodermal Tumors .
C04.557.580.625.600 Neoplasms, Neuroepithelial .
C04.557.580.625.600.380 Glioma .
C04.557.580.625.600.380.080 Astrocytoma .
D02 Organic Chemicals .
D02.065 Amides .
D02.065.277 Benzamides .
D02.065.277.650 Procainamide .
D02.241 Carboxylic Acids .
D02.241.223 Acids, Carbocyclic .
D02.241.223.100 Benzoates .
D02.241.223.100.050 Aminobenzoates .
D02.241.223.100.050.500 para-Aminobenzoates .
D02.241.223.100.050.500.875 Procainamide .
D02.241.223.100.100 Benzamides .
D02.241.223.100.100.650 Procainamide .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.127 Benzoates .
D02.455.426.559.389.127.020 Aminobenzoates .
D02.455.426.559.389.127.020.937 para-Aminobenzoates .
D02.455.426.559.389.127.020.937.875 Procainamide .
D02.455.426.559.389.127.085 Benzamides .
D02.455.426.559.389.127.085.650 Procainamide .
D02.455.526 Hydrocarbons, Halogenated .
D02.455.526.728 Mustard Compounds .
D02.455.526.728.650 Nitrogen Mustard Compounds .
D02.455.526.728.650.730 Phosphoramide Mustards .
D02.455.526.728.650.730.243 Cyclophosphamide .
D02.705 Organophosphorus Compounds .
D02.705.672 Phosphoramides .
D02.705.672.500 Phosphoramide Mustards .
D02.705.672.500.243 Cyclophosphamide .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.773 Pyrrolidines .
D03.383.773.728 Procyclidine .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.682 Oxidoreductases .
D08.811.682.660 Oxidoreductases Acting on CH-CH Group Donors .
D08.811.682.660.600 Protoporphyrinogen Oxidase .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.395 Glycoproteins .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.294 Endothelial Protein C Receptor .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.294 Endothelial Protein C Receptor .
D12.776.543.697 Protoporphyrinogen Oxidase .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.045 Endothelial Protein C Receptor .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Cyclophosphamide .
B-518 .
Cyclophosphamide Anhydrous .
Cyclophosphamide Monohydrate .
Cyclophosphamide, (R)-Isomer .
Cyclophosphamide, (S)-Isomer .
Cyclophosphane .
Cytophosphan .
Cytophosphane .
Cytoxan .
Endoxan .
NSC-26271 .
Neosar .
Procytox .
Sendoxan .
Anhydrous, Cyclophosphamide .
B 518 .
B518 2751 .
Monohydrate, Cyclophosphamide .
NSC 26271 .
NSC26271 .
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. .
1.00
 
Protoporphyrinogen Oxidase .
Protoporphyrinogen Dehydrogenase .
Protoporphyrinogen IX Oxidase .
Protoporphyrinogenase .
Protox .
Dehydrogenase, Protoporphyrinogen .
Oxidase, Protoporphyrinogen .
Oxidase, Protoporphyrinogen IX .
A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of protoporphyrinogen IX (Protogen) to protoporphyrin IX (Proto IX). It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of protoporphyrinogen oxidase. .
0.56
 
Endothelial Protein C Receptor .
Antigen, CD201 .
Antigens, CD201 .
CD201 Antigen .
EPCR 33281 .
PROCR .
Protein C Receptor .
CD201 Antigens .
Receptor, Protein C .
A glycosylated transmembrane receptor for PROTEIN C that is highly expressed by endothelial cells on the surface of large blood vessels in the heart and lungs. It facilitates protein C activation by the THROMBIN and THROMBOMODULIN complex in blood coagulation. .
0.54
 
Raccoons .
Procyons .
Raccoon .
Procyon .
Carnivores of the genus Procyon of the family PROCYONIDAE. Two subgenera and seven species are currently recognized. They range from southern Canada to Panama and are found in several of the Caribbean Islands. .
0.54
 
Procyclidine .
Arpicolin .
Kemadren .
Kemadrin .
Mucinil .
Osnervan .
Procyclid .
Procyclidine Hydrochloride .
Tricyclamol .
Hydrochloride, Procyclidine .
A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. .
0.51
 
Procainamide .
Apo-Procainamide .
Biocoryl .
Novocainamide .
Novocamid .
Procainamide Hydrochloride .
Procamide .
Procan .
Procan SR .
Procanbid .
Pronestyl .
Rhythmin .
Amide, Procaine .
Hydrochloride, Procainamide .
Procaine Amide .
A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. .
0.51
 
Monocyte-Macrophage Precursor Cells .
Monoblast .
Monocyte-Macrophage Progenitor Cells .
Promonocyte .
Cell, Monocyte-Macrophage Precursor .
Cell, Monocyte-Macrophage Progenitor .
Cells, Monocyte-Macrophage Precursor .
Cells, Monocyte-Macrophage Progenitor .
Monocyte Macrophage Precursor Cells .
Monocyte Macrophage Progenitor Cells .
Monocyte-Macrophage Precursor Cell .
Monocyte-Macrophage Progenitor Cell .
Precursor Cell, Monocyte-Macrophage .
Precursor Cells, Monocyte-Macrophage .
Progenitor Cell, Monocyte-Macrophage .
Progenitor Cells, Monocyte-Macrophage .
Monoblasts .
Promonocytes .
Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES. .
0.48
 
Astrocytoma .
Anaplastic Astrocytoma .
Astrocytoma, Grade I .
Astrocytoma, Grade II .
Astrocytoma, Grade III .
Astrocytoma, Protoplasmic .
Astroglioma .
Cerebral Astrocytoma .
Childhood Cerebral Astrocytoma .
Fibrillary Astrocytoma .
Gemistocytic Astrocytoma .
Intracranial Astrocytoma .
Juvenile Pilocytic Astrocytoma .
Pilocytic Astrocytoma .
Subependymal Giant Cell Astrocytoma .
Anaplastic Astrocytomas .
Astrocytic Glioma .
Astrocytic Gliomas .
Astrocytoma, Anaplastic .
Astrocytoma, Cerebral .
Astrocytoma, Childhood Cerebral .
Astrocytoma, Fibrillary .
Astrocytoma, Gemistocytic .
Astrocytoma, Intracranial .
Astrocytoma, Juvenile Pilocytic .
Astrocytoma, Pilocytic .
Astrocytomas .
Astrocytomas, Anaplastic .
Astrocytomas, Cerebral .
Astrocytomas, Childhood Cerebral .
Astrocytomas, Fibrillary .
Astrocytomas, Gemistocytic .
Astrocytomas, Grade I .
Astrocytomas, Grade II .
Astrocytomas, Grade III .
Astrocytomas, Intracranial .
Astrocytomas, Juvenile Pilocytic .
Astrocytomas, Pilocytic .
Astrocytomas, Protoplasmic .
Astrogliomas .
Cerebral Astrocytoma, Childhood .
Cerebral Astrocytomas .
Cerebral Astrocytomas, Childhood .
Childhood Cerebral Astrocytomas .
Fibrillary Astrocytomas .
Gemistocytic Astrocytomas .
Gliomas, Astrocytic .
Grade I Astrocytoma .
Grade I Astrocytomas .
Grade II Astrocytoma .
Grade II Astrocytomas .
Grade III Astrocytoma .
Grade III Astrocytomas .
Intracranial Astrocytomas .
Juvenile Pilocytic Astrocytomas .
Mixed Oligoastrocytoma .
Mixed Oligoastrocytomas .
Oligoastrocytomas, Mixed .
Pilocytic Astrocytoma, Juvenile .
Pilocytic Astrocytomas .
Pilocytic Astrocytomas, Juvenile .
Protoplasmic Astrocytoma .
Protoplasmic Astrocytomas .
Astrocytoma, Subependymal Giant Cell .
Glioma, Astrocytic .
Oligoastrocytoma, Mixed .
Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) .
0.47